EDWARD SALIBA: Open Payments
NPI 1710451232 · PARMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 13 payments from 8 companies in 2025. Trend: 2023 $394 · 2024 $301 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| Exact Sciences Corporation | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Novo Nordisk Inc | 2 | $35 |
| ABBVIE INC. | 1 | $21 |
| Optinose US, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: AIRSUPRA, Cologuard Collection Kit, XIFAXAN, QULIPTA, Xhance, SHINGRIX, Ozempic, CAMZYOS.
Industry payments across OH — which companies pay providers there.
